We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Sues Generic Companies to Protect Entresto Patent
Novartis Sues Generic Companies to Protect Entresto Patent
Novartis has filed a complaint against several generic drugmakers for allegedly infringing on a patent for its blockbuster heart failure drug Entresto (sacubitril/valsartan).